Inotiv, Inc. - Common Stock NOTV 深 沪
已收盘 12-12 16:00:00 美东时间
0.7642
-0.039
-4.91%
华盛通- 最 高0.8098
- 今 开0.80
- 成交量 20.75万股
- 最 低 0.7566
- 昨 收 0.8037
- 总市值 2625.43万
- 52周最高 5.67
- 市盈率 静 --
- 换手率 0.60%
- 52周最低 0.657
- 委 比 -78.31%
- 总股本 3435.53万
- 历史最高 60.66
- 量 比 0.62
- 振 幅 6.62%
- 历史最低 0.60
- 每 手 1
- 风险率 1.16%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多12 Health Care Stocks Moving In Friday's After-Market Session
Gainers GT Biopharma (NASDAQ:GTBP) shares moved upwards by 6.6% to $0.65 durin...
12-06 05:05
美股大行评级 | 潜在涨幅218.88%！Kyverna Therapeutics获摩根士丹利升目标价至25美元，维持"超配"评级
今日重点评级关注：摩根士丹利：维持Kyverna Therapeutics"超配"评级，目标价从20美元升至25美元；Maxim Group：维持Capricor Therapeutics"买入"评级，目标价从25美元升至50美元
12-05 08:35
Lake Street Maintains Buy on Inotiv, Lowers Price Target to $3
Lake Street analyst Frank Takkinen maintains Inotiv (NASDAQ:NOTV) with a Buy and lowers the price target from $5 to $3.
12-05 02:02
Inotiv Q4 EPS $(0.25) Beats $(0.46) Estimate, Sales $138.142M Beat $135.605M Estimate
Inotiv (NASDAQ:NOTV) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.46) by 45.65 percent. This is a 65.75 percent increase over losses of $(0.73) per share from the same
12-04 05:06
Earnings Scheduled For December 3, 2025
Companies Reporting Before The Bell • Yuanbao (NASDAQ:YB) is likely to report e...
12-03 19:11
Insights Ahead: Inotiv's Quarterly Earnings
Inotiv (NASDAQ:NOTV) is gearing up to announce its quarterly earnings on Wednes...
12-02 23:02
Financial Times Reported FDA To End Requirement For Lab Monkeys In Some Drug Safety Studies
https://www.ft.com/content/5a14beae-0eb6-4eec-ad36-0f13d4fc4a56
12-02 18:23
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Olema Pharmaceuticals (NASDAQ:OLMA) stock increased by 137.7% to $20.2...
11-19 01:06
Inotiv shares are trading higher after the company reported preliminary Q4 and FY25 revenue results.
Inotiv shares are trading higher after the company reported preliminary Q4 and ...
11-18 05:33
Inotiv Announces Preliminary Expected Q4 Revenue Of $137.5M - $138.5M And Preliminary Expected FY25 Revenue Of $512.5M - $513.5M
Preliminary Expected Fourth Quarter 2025 Revenue of $137.5 to $138.5 MillionPreliminary Expected Full Year 2025 Revenue of $512.5 to $513.5 MillionUpdated Time of Company Presentation at Jefferies Global Healthcare
11-18 05:09
